28.89 
0.16(0.57%) 4:00PM EDT|After Hours
:
28.89 0.00 (0.00%) 5:27PM EDT
| Prev Close: | 28.73 |
|---|
| Open: | 28.58 |
|---|
| Bid: | 28.87 x 1000 |
|---|
| Ask: | 28.90 x 1200 |
|---|
| 1y Target Est: | 31.72 |
|---|
| Beta: | 0.81 |
|---|
| Next Earnings Date: | 29-Oct-13 |
|---|
| Day's Range: | 28.52 - 28.95 |
|---|
| 52wk Range: | 23.55 - 31.15 |
|---|
| Volume: | 23,481,453 |
|---|
| Avg Vol (3m): | 27,920,100 |
|---|
| Market Cap: | 191.26B |
|---|
| P/E (ttm): | 8.02 |
|---|
| EPS (ttm): | 3.60 |
|---|
| Div & Yield: | 0.96 (3.30%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Featured on Yahoo! Finance
Headlines
- Apple Now Holds 10% of All Corporate Cash: Moody'sat The Wall Street Journal(Tue 4:45PM EDT)
- Does Lexicon Own the Future of Type 2 Diabetes?at Motley Fool(Tue 3:45PM EDT)
- Top-line Data on Astellas' IsavuconazoleZacks(Tue 3:30PM EDT)
- Merck’s Big Bet on R&D Founders, and 8,500 Job Cuts Ensueat BusinessWeek(Tue 3:07PM EDT)
- No Shutdown for the Markets as the Dow Runs Higherat Motley Fool(Tue 2:48PM EDT)
- Merck rises after announcing major restructuringat theflyonthewall.com(Tue 2:44PM EDT)
- Earnings Outliers: The Real Deal on Corporate Profitabilityat BusinessWeek(Tue 2:39PM EDT)
- Merck to slash annual costs by $2.5 billion, cut 8,500 jobsReuters(Tue 2:08PM EDT)
- Merck to slash annual costs by $2.5 bln, cut 8,500 jobsReuters(Tue 2:06PM EDT)
- Candy Crush IPO Needs a Better Innovation Planat BusinessWeek(Tue 1:25PM EDT)
- Midday Glance: Pharmaceuticals companiesAP(Tue 1:22PM EDT)
- Merck Restructuring Plan To Save $2.5 Bil Lifts Stockat Investor's Business Daily(Tue 12:25PM EDT)
- Merck Cuts 8,500 Jobs, Amazon Hires 70,000 For Holiday Season As BLS Suspends Jobs Reportat Forbes(Tue 12:00PM EDT)
- Tech Cash Hoard Grows as Activists Press Apple Payoutsat TheStreet(Tue 11:21AM EDT)
- Netflix Rides Hiked Price Target, Pfizer Drug Hits a Snag, and 3 More Hot Stocksat Wall St. Cheat Sheet(Tue 11:01AM EDT)
Key Statistics
| Forward P/E (1 yr): | 12.56 |
|---|
| P/S (ttm): | 3.36 |
|---|
| Ex-Dividend Date: | 31-Jul-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 2.16 |
|---|
| Quarterly EPS Est
(Sep-13)
: | 0.56 |
|---|
| Mean Recommendation*: | 2.3 |
|---|
| PEG Ratio (5 yr expected): | 4.59 |
|---|
Business Summary
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells medicines for people and animals worldwide. Its Primary Care segment offers human prescription pharmaceutical products primarily prescribed by primary-care phys...
View More